Stay updated on Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3 without changing the displayed study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:44:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:55:35.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:25:49.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 in place of v3.4.2 as part of a minor site update.
    Difference
    0.0%
    Check dated 2026-03-12T02:15:31.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse in government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:41:41.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A government funding notice about potential delays and the NIH Clinical Center's status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:16:37.000Z thumbnail image

Stay in the know with updates to Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.